Cardiovascular Chinese Research Center   Report issue

For profit
Founded: Shanghai China (2015)

Organization Overview

First Clinical Trial
2018
NCT03469206
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Cardiovascular Chinese Research Center

Active Ingredients

Drugs in Other Trials (1)

alteplase (Activase) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1